OTC Markets EXMKT - Delayed Quote USD
Arch Therapeutics, Inc. (ARTH)
0.1608
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 155.95k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| ABRAMS MICHAEL S Chief Investment Officer | Purchase at price 1.47 per share. | Direct | 15,129 | Aug 31, 2023 |
| NORCHI TERRENCE W Chief Executive Officer | Purchase at price 1.47 per share. | Direct | 10,087 | Aug 31, 2023 |
| HICKS LAURENCE M. Director | Purchase at price 1.47 per share. | Indirect | 15,129 | Aug 31, 2023 |
Related Tickers
MTEM Molecular Templates, Inc.
0.0001
0.00%
BETRF BetterLife Pharma Inc.
0.0680
0.00%
AURX Nuo Therapeutics, Inc.
1.5000
+1.35%
ATHXQ Athersys, Inc.
0.0000
0.00%
MSCLF Satellos Bioscience Inc.
0.5020
0.00%
NYMXF Nymox Pharmaceutical Corporation
0.1178
0.00%
NGENF NervGen Pharma Corp.
2.1300
-0.93%
MAZE Maze Therapeutics, Inc.
9.55
-3.14%
MDNAF Medicenna Therapeutics Corp.
0.7590
-0.78%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%